Table Filtering
Submissions
GlyTouCan
Glycan Structure Repository
GlyComb
Glycoconjugate Repository
GlycoPOST
Glycomics MS raw data Repository
UniCarb-DR
Glycomics MS Repository for glycan annotations from GlycoWorkbench
All Resources
Genes / Proteins / Lipids Glycans / Glycoconjugates Glycomes Pathways / Interactions / Diseases / Organisms
GlycoNAVI Proteins
GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.
| Source | Last Updated |
|---|---|
| GlycoNAVI Proteins | November 21, 2024 |
| PDB ID | UniProt ID ▲ | Title | Descriptor |
|---|---|---|---|
| 4E36 | Q6P179 | Crystal structure of the human Endoplasmic Reticulum Aminopeptidase 2 variant N392K | |
| 4JBS | Q6P179 | Crystal structure of the human Endoplasmic Reticulum Aminopeptidase 2 in complex with PHOSPHINIC PSEUDOTRIPEPTIDE inhibitor. | |
| 5AB0 | Q6P179 | Crystal structure of aminopeptidase ERAP2 with ligand | |
| 5AB2 | Q6P179 | Crystal structure of aminopeptidase ERAP2 with ligand | |
| 5CU5 | Q6P179 | Crystal structure of ERAP2 without catalytic Zn(II) atom | |
| 5J6S | Q6P179 | Crystal structure of Endoplasmic Reticulum Aminopeptidase 2 (ERAP2) in complex with a hydroxamic derivative ligand | |
| 5K1V | Q6P179 | Crystal structure of Endoplasmic Reticulum aminopeptidase 2 (ERAP2) in complex with a diaminobenzoic acid derivative ligand. | |
| 7P7P | Q6P179 | Crystal structure of ERAP2 aminopeptidase in complex with phosphinic pseudotripeptide((1R)-1-Amino-3-phenylpropyl){(2S)-3-[((2S)-1-amino-1-oxo-3-phenylpropan-2-yl)amino]-2-{[3-(2-hydroxyphenyl)-isoxazol-5-yl]methyl}-3-oxopropyl}phosphinic acid | |
| 7PFS | Q6P179 | Crystal structure of ERAP2 aminopeptidase in complex with phosphinic pseudotripeptide ((1R)-1-Amino-3-phenylpropyl){2-([1,1:3,1-terphenyl]-5-ylmethyl)-3-[((2S)-1-amino-1-oxo-3-phenylpropan-2-yl)-amino]-3-oxopropyl}phosphinic acid | |
| 7NSK | Q6P179 | Endoplasmic reticulum aminopeptidase 2 complexed with a hydroxamic ligand | |
| 7NUP | Q6P179 | Endoplasmic reticulum aminopeptidase 2 complexed with a mixed hydroxamic and sulfonyl ligand | |
| 5WKI | Q6P4G7 | Crystal structure of PG90 TCR-CD1b-PG complex | T-cell surface glycoprotein CD1b, Beta-2-microglobulin, T-cell receptor alpha variable 26-1,TRA@ protein, PG90 TCR beta chain |
| 9B8O | Q6P503 | Synaptic Vesicle V-ATPase with synaptophysin and SidK, State 3, Vo | |
| 9BRD | Q6P503 | Synaptic Vesicle V-ATPase with synaptophysin and SidK, State 3 | |
| 7RTW | Q6P5F7 | Cryo-EM structure of a TTYH3 cis-dimer | |
| 6WM3 | Q6P5S7 | Human V-ATPase in state 2 with SidK and ADP | V-type proton ATPase 116 kDa subunit a isoform 1, V-type proton ATPase subunit C 1, V-type proton ATPase subunit E 1, V-type proton ATPase subunit G 1, V-type proton ATPase subunit e 1, Ribonuclease kappa (E.C.3.1.-.-), V-type proton ATPase subunit H, V-type proton ATPase subunit S1, Renin receptor, V-type proton ATPase 21 kDa proteolipid subunit, V-type proton ATPase 16 kDa proteolipid subunit, V-type proton ATPase subunit d 1, V-type proton ATPase catalytic subunit A (E.C.7.1.2.2), V-type proton ATPase subunit B, brain isoform, V-type proton ATPase subunit D, V-type proton ATPase subunit F |
| 6WLW | Q6P5S7 | The Vo region of human V-ATPase in state 1 (focused refinement) | V-type proton ATPase 116 kDa subunit a isoform 1, V-type proton ATPase subunit S1, Renin receptor, V-type proton ATPase 21 kDa proteolipid subunit, V-type proton ATPase 16 kDa proteolipid subunit, V-type proton ATPase subunit d 1, V-type proton ATPase subunit e 1, Ribonuclease kappa (E.C.3.1.-.-) |
| 7U4T | Q6P5S7 | Human V-ATPase in state 2 with SidK and mEAK-7 | |
| 6WM2 | Q6P5S7 | Human V-ATPase in state 1 with SidK and ADP | V-type proton ATPase 116 kDa subunit a isoform 1, V-type proton ATPase subunit C 1, V-type proton ATPase subunit E 1, V-type proton ATPase subunit G 1, V-type proton ATPase subunit e 1, Ribonuclease kappa (E.C.3.1.-.-), V-type proton ATPase subunit H, V-type proton ATPase catalytic subunit A (E.C.7.1.2.2), V-type proton ATPase subunit B, brain isoform, k, V-type proton ATPase subunit D, V-type proton ATPase subunit F, V-type proton ATPase subunit S1, Renin receptor, V-type proton ATPase 21 kDa proteolipid subunit, V-type proton ATPase 16 kDa proteolipid subunit, V-type proton ATPase subunit d 1 |
| 6WM4 | Q6P5S7 | Human V-ATPase in state 3 with SidK and ADP | V-type proton ATPase catalytic subunit A (E.C.7.1.2.2), V-type proton ATPase subunit B, brain isoform, SidK, V-type proton ATPase 116 kDa subunit a isoform 1, V-type proton ATPase subunit C 1, V-type proton ATPase subunit E 1, V-type proton ATPase subunit G 1, V-type proton ATPase subunit D, V-type proton ATPase subunit F, V-type proton ATPase subunit S1, Renin receptor, V-type proton ATPase 21 kDa proteolipid subunit, V-type proton ATPase 16 kDa proteolipid subunit, V-type proton ATPase subunit d 1, V-type proton ATPase subunit e 1, Ribonuclease kappa (E.C.3.1.-.-), V-type proton ATPase subunit H |
| 7UNF | Q6P5S7 | CryoEM structure of a mEAK7 bound human V-ATPase complex | |
| 2NXY | Q6P5S8 | HIV-1 gp120 Envelope Glycoprotein(S334A) Complexed with CD4 and Antibody 17b | |
| 2NXZ | Q6P5S8 | HIV-1 gp120 Envelope Glycoprotein (T257S, S334A, S375W) Complexed with CD4 and Antibody 17b | |
| 2NY0 | Q6P5S8 | HIV-1 gp120 Envelope Glycoprotein (M95W, W96C, T257S, V275C, S334A, S375W, A433M) Complexed with CD4 and Antibody 17b | |
| 2NY1 | Q6P5S8 | HIV-1 gp120 Envelope Glycoprotein (I109C, T257S, S334A, S375W, Q428C) Complexed with CD4 and Antibody 17b | |
| 2NY2 | Q6P5S8 | HIV-1 gp120 Envelope Glycoprotein (T123C, T257S, S334A, S375W, G431C) Complexed with CD4 and Antibody 17b | |
| 2NY3 | Q6P5S8 | HIV-1 gp120 Envelope Glycoprotein (K231C, T257S, E267C, S334A, S375W) Complexed with CD4 and Antibody 17b | |
| 2NY4 | Q6P5S8 | HIV-1 gp120 Envelope Glycoprotein (K231C, T257S, E268C, S334A, S375W) Complexed with CD4 and Antibody 17b | |
| 2NY5 | Q6P5S8 | HIV-1 gp120 Envelope Glycoprotein (M95W, W96C, I109C, T257S, V275C, S334A, S375W, Q428C, A433M) Complexed with CD4 and Antibody 17b | |
| 2NY6 | Q6P5S8 | HIV-1 gp120 Envelope Glycoprotein (M95W, W96C, I109C, T123C, T257S, V275C,S334A, S375W, Q428C, G431C) Complexed with CD4 and Antibody 17b | |
| 6AL5 | Q6P5S8 | COMPLEX BETWEEN CD19 (N138Q MUTANT) AND B43 FAB | |
| 6AL5 | Q6P5S8 | COMPLEX BETWEEN CD19 (N138Q MUTANT) AND B43 FAB | |
| 6V8Z | Q6P5S8 | VRC03 and 10-1074 Bound BG505 F14 HIV-1 SOSIP Envelope Trimer Structure | envelope glycoprotein gp120, envelope glycoprotein gp41, VRC03 VH, 10-1074 VH, 10-1074 VL, VRC03 VL |
| 6V8Z | Q6P5S8 | VRC03 and 10-1074 Bound BG505 F14 HIV-1 SOSIP Envelope Trimer Structure | envelope glycoprotein gp120, envelope glycoprotein gp41, VRC03 VH, 10-1074 VH, 10-1074 VL, VRC03 VL |
| 6TUZ | Q6P988 | Theophylline-Notum complex | |
| 6TV4 | Q6P988 | CFF-Notum complex | |
| 6R8P | Q6P988 | Notum fragment 723 | Palmitoleoyl-protein carboxylesterase NOTUM (E.C.3.1.1.98) |
| 6ZVL | Q6P988 | ARUK3000263 complex with Notum | |
| 7B37 | Q6P988 | Notum complex with ARUK3003718 | |
| 6YV0 | Q6P988 | STRUCTURE OF THE WNT DEACYLASE NOTUM IN COMPLEX WITH A PYRROLIDINE-3-CARBOXYLIC ACID FRAGMENT 587 | |
| 6YXI | Q6P988 | Structure of Notum in complex with a 1-(3-Chlorophenyl)-2,5-dimethyl-1H-pyrrole-3-carboxylic acid inhibitor | |
| 6T2H | Q6P988 | Furano[2,3-d]prymidine amides as Notum inhibitors | |
| 6T2K | Q6P988 | Furano[2,3-d]prymidine amides as Notum inhibitors | |
| 6TR6 | Q6P988 | N-acetylserotonin-Notum complex | |
| 7B7W | Q6P988 | Notum-Fragment049 | |
| 6TR5 | Q6P988 | Melatonin-Notum complex | |
| 6TR7 | Q6P988 | N-[2-(5-fluoro-1H-indol-3-yl)ethyl]acetamide-Notum complex | |
| 6YUW | Q6P988 | STRUCTURE OF THE WNT DEACYLASE NOTUM IN COMPLEX WITH A PYRROLE-3-CARBOXYLIC ACID FRAGMENT 454 | |
| 6R8Q | Q6P988 | STRUCTURE OF THE WNT DEACYLASE NOTUM IN COMPLEX WITH A BENZOTRIAZOLE FRAGMENT | |
| 6R8R | Q6P988 | Structure of the Wnt deacylase Notum in complex with isoquinoline 45 |
